Australian researchers have joined with leading academics from around the world to call for a new focus to improve systems of health in low and middle-income countries in a paper today published in the highly respected The Lancet.
The George Institute for Global Health has been awarded just over $10 million in research grants from the National Health and Medical Research Council (NHMRC) for projects scheduled to commence in 2011.
A new systematic review has provided much needed clarity for clinicians across the world, confirming the benefits of cholesterol medication, for patients at high risk of heart disease. The analysis, undertaken at The George Institute, showed that fibrates, a commonly used medication used to improve cholesterol and prevent heart disease, provide a 10-15% reduced risk of serious cardiovascular events, mainly due to a reduction in the risk of heart attack.
A new study published today by Sydney-based The George Institute for Global Health has found that people with type 2 diabetes who suffer episodes of critically low blood sugar levels (severe hypoglycemia) are at greater risk of suffering subsequent vascular problems such as a heart attack, stroke and kidney disease, as well as non-vascular problems such as cancer and respiratory conditions.
New research has revealed that the number of people dying from smoking-related lung cancer over the next two decades is expected to double in the Asia-Pacific region if current smoking habits remain unchanged.
Treat the snoring and you may be less likely to have a heart attack or stroke. This is the premise of an international study being coordinated by Australian researchers at the George Institute for Global Health.